JGVRX
Price
$41.74
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
RGEBX
Price
$73.96
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

JGVRX vs RGEBX

Header iconJGVRX vs RGEBX Comparison
Open Charts JGVRX vs RGEBXBanner chart's image
JPMorgan Growth Advantage R5
Price$41.74
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$73.96
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JGVRX vs RGEBX Comparison Chart
Loading...
VS
JGVRX vs. RGEBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGVRX is a StrongBuy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 284B vs. JGVRX (20B). RGEBX pays higher dividends than JGVRX: RGEBX (0.16) vs JGVRX (0.00). JGVRX was incepted earlier than RGEBX: JGVRX (16 years) vs RGEBX (10 years). JGVRX is a more actively managed with annual turnover of: 38.00 vs. RGEBX (31.00). JGVRX has a lower initial minimum investment than RGEBX: JGVRX (0) vs RGEBX (250). JGVRX annual gain was more profitable for investors over the last year : 32.22 vs. RGEBX (22.86). JGVRX return over 5 years is better than : 78.29 vs. RGEBX (47.60).
JGVRXRGEBXJGVRX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years10 years-
Gain YTD20.99218.896111%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets20B284B7%
Annual Yield % from dividends0.000.16-
Returns for 1 year32.2222.86141%
Returns for 3 years7.24-4.80-151%
Returns for 5 years78.2947.60164%
Returns for 10 years172.8556.25307%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLNE158.621.25
+0.79%
Hamilton Lane
IE7.390.03
+0.41%
Ivanhoe Electric
HLN10.55-0.10
-0.94%
Haleon plc
COMM5.60-0.08
-1.41%
CommScope Holding Company
QNCX0.74-0.02
-2.65%
Quince Therapeutics